Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 5/2012

01.09.2012 | Original Article

Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative?

verfasst von: Tamaris Zwickler, Gisela Haege, Alina Riderer, Friederike Hörster, Georg F. Hoffmann, Peter Burgard, Stefan Kölker

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Recurrent, life-threatening metabolic decompensations often occur in patients with methylmalonic aciduria (MMAuria). Our study evaluated (impending) metabolic decompensations in these patients aiming to identify the most frequent and reliable clinical and biochemical abnormalities that could be helpful for decision-making on when to start an emergency treatment. Seventy-six unscheduled and 179 regular visits of 10 patients with confirmed MMAuria continuously followed by our metabolic centre between 1975 and 2009 were analysed. The most frequent symptom of an impending acute metabolic decompensation was vomiting (90% of episodes), whereas symptoms of intercurrent infectious disease (29%) or other symptoms (such as food refusal and impaired consciousness) were found less often. Thirty-five biochemical parameters were included in the analysis. Among them, pathological changes of acid–base balance reflecting metabolic acidosis with partial respiratory compensation (decreased pH, pCO2, standard bicarbonate, and base excess) and elevated ammonia were the most reliable biochemical parameters for the identification of a metabolic decompensation and the estimation of its severity. In contrast, analyses of organic acids, acylcarnitines and carnitine status were less discriminative. In conclusion, careful history taking and identification of suspicious symptoms in combination with a small number of rapidly available biochemical parameters are helpful to differentiate compensated metabolic condition and (impending) metabolic crisis and to decide when to start an emergency treatment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Abdi H (2007) Bonferroni and Sidak corrections for multiple comparisons. In: Salkind NJ (ed) Encyclopedia of Measurement and Statistics. Sage, Thousand Oaks, pp 103–107 Abdi H (2007) Bonferroni and Sidak corrections for multiple comparisons. In: Salkind NJ (ed) Encyclopedia of Measurement and Statistics. Sage, Thousand Oaks, pp 103–107
Zurück zum Zitat Baumgartner ER, Viardot C (1995) Long-term follow-up of 77 patients with isolated methylmalonic acidaemia. J Inher Metab Dis 18:138–142CrossRef Baumgartner ER, Viardot C (1995) Long-term follow-up of 77 patients with isolated methylmalonic acidaemia. J Inher Metab Dis 18:138–142CrossRef
Zurück zum Zitat Coude FX, Sweetman L, Nyhan WL (1979) Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J Clin Invest 64:1544–1551PubMedCentralPubMedCrossRef Coude FX, Sweetman L, Nyhan WL (1979) Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J Clin Invest 64:1544–1551PubMedCentralPubMedCrossRef
Zurück zum Zitat Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C (2006) Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 142C:104–112PubMedCrossRef Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C (2006) Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 142C:104–112PubMedCrossRef
Zurück zum Zitat Edgington ES (1995) Randomization tests, 3rd edn. Marcel-Dekker, New York, pp 1–409 Edgington ES (1995) Randomization tests, 3rd edn. Marcel-Dekker, New York, pp 1–409
Zurück zum Zitat Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417:447–452PubMed Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417:447–452PubMed
Zurück zum Zitat Fenton WA, Gravel RA, Rosenblatt DS (2001) Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 2165–2193 Fenton WA, Gravel RA, Rosenblatt DS (2001) Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 2165–2193
Zurück zum Zitat Hörster F, Garbade SF, Zwickler T et al. (2009) Prediction of outcome in isolated methylmalonic acidurias: Combined use of clinical and biochemical parameters. J Inherit Metab Dis 32:630–639PubMedCrossRef Hörster F, Garbade SF, Zwickler T et al. (2009) Prediction of outcome in isolated methylmalonic acidurias: Combined use of clinical and biochemical parameters. J Inherit Metab Dis 32:630–639PubMedCrossRef
Zurück zum Zitat Leonard JV, Vijayaraghavan S, Walter JH (2003) The impact of screening for propionic and methylmalonic acidaemia. Eur J Pediatr 162:S21–S24PubMedCrossRef Leonard JV, Vijayaraghavan S, Walter JH (2003) The impact of screening for propionic and methylmalonic acidaemia. Eur J Pediatr 162:S21–S24PubMedCrossRef
Zurück zum Zitat Marquard J, El Scheich T, Klee D, Schmitt M, Meissner T, Mayatepek E, Oh J (2011) Chronic pancreatitis in branched-chain organic acidurias – a case of methylmalonic aciduria and an overview of the literature. Eur J Pediatr 170:241–245PubMedCrossRef Marquard J, El Scheich T, Klee D, Schmitt M, Meissner T, Mayatepek E, Oh J (2011) Chronic pancreatitis in branched-chain organic acidurias – a case of methylmalonic aciduria and an overview of the literature. Eur J Pediatr 170:241–245PubMedCrossRef
Zurück zum Zitat Morath MA, Okun JG, Müller IB, Sauer SW, Hörster F, Hoffmann GF, Kölker S (2008) Neurodegeneration and chronic renal failure in methylmalonic aciduria-A pathophysiological approach. J Inherit Metab Dis 31:35–43PubMedCrossRef Morath MA, Okun JG, Müller IB, Sauer SW, Hörster F, Hoffmann GF, Kölker S (2008) Neurodegeneration and chronic renal failure in methylmalonic aciduria-A pathophysiological approach. J Inherit Metab Dis 31:35–43PubMedCrossRef
Zurück zum Zitat National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S246 National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S246
Zurück zum Zitat Ogier de Baulny H, Benoist JF, Rigal O, Touati G, Rabier D, Saudubray JM (2005) Methylmalonic and propionic acidaemias: Management and outcome. J Inherit Metab Dis 28:415–423PubMedCrossRef Ogier de Baulny H, Benoist JF, Rigal O, Touati G, Rabier D, Saudubray JM (2005) Methylmalonic and propionic acidaemias: Management and outcome. J Inherit Metab Dis 28:415–423PubMedCrossRef
Zurück zum Zitat Okun JG, Hörster F, Farkas LM, Feyh P, Hinz A, Sauer S, Hoffmann GF, Unsicker K, Mayatepek E, Kölker S (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem 277:14674–14680PubMed Okun JG, Hörster F, Farkas LM, Feyh P, Hinz A, Sauer S, Hoffmann GF, Unsicker K, Mayatepek E, Kölker S (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem 277:14674–14680PubMed
Zurück zum Zitat Saudubray JM, Nassogne MC, de Lonlay P, Touati G (2002) Clinical approach to inherited metabolic disorders in neonates: an overview. Semin Neonatol 7:3–15PubMedCrossRef Saudubray JM, Nassogne MC, de Lonlay P, Touati G (2002) Clinical approach to inherited metabolic disorders in neonates: an overview. Semin Neonatol 7:3–15PubMedCrossRef
Zurück zum Zitat Sauer SW, Okun JG, Hoffmann GF, Kölker S, Morath MA (2008) Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on mitochondrial energy metabolism. Biochim Biophys Acta 1777:1276–1282PubMedCrossRef Sauer SW, Okun JG, Hoffmann GF, Kölker S, Morath MA (2008) Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on mitochondrial energy metabolism. Biochim Biophys Acta 1777:1276–1282PubMedCrossRef
Zurück zum Zitat Schwab MA, Sauer SW, Okun JG et al. (2006) Secondary mitochondrial dysfunction in propionic aciduria, a pathogenic role for endogenous mitochondrial toxins. Biochem J 398(1):107–112PubMedCentralPubMedCrossRef Schwab MA, Sauer SW, Okun JG et al. (2006) Secondary mitochondrial dysfunction in propionic aciduria, a pathogenic role for endogenous mitochondrial toxins. Biochem J 398(1):107–112PubMedCentralPubMedCrossRef
Zurück zum Zitat Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637PubMedCentralPubMedCrossRef Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637PubMedCentralPubMedCrossRef
Zurück zum Zitat Smucker MD, Allan J., Carterette B (2007) A comparison of statistical significance tests for information retrieval evaluation. Proceedings of the sixteenth ACM conference on Conference on Information and Knowledge Management (CIKM). November 05–10, 2007, Lisbon, Portugal. ACM, New York, pp 623–632 Smucker MD, Allan J., Carterette B (2007) A comparison of statistical significance tests for information retrieval evaluation. Proceedings of the sixteenth ACM conference on Conference on Information and Knowledge Management (CIKM). November 05–10, 2007, Lisbon, Portugal. ACM, New York, pp 623–632
Zurück zum Zitat Thompson GN, Chalmers RA, Walter JH et al. (1990) The use of metronidazole in the management of methylmalonic and propionic acidemias. Eur J Pediatr 149:792–796PubMedCrossRef Thompson GN, Chalmers RA, Walter JH et al. (1990) The use of metronidazole in the management of methylmalonic and propionic acidemias. Eur J Pediatr 149:792–796PubMedCrossRef
Zurück zum Zitat Walter JH (2003) L-Carnitine in inborn errors of metabolism: What is the evidence? J Inherit Metab Dis 26:181–188PubMedCrossRef Walter JH (2003) L-Carnitine in inborn errors of metabolism: What is the evidence? J Inherit Metab Dis 26:181–188PubMedCrossRef
Zurück zum Zitat Walter JH, MacDonald A (2006) The use of amino acid supplements in inherited metabolic disease. J Inherit Metab Dis 29:279–280PubMedCrossRef Walter JH, MacDonald A (2006) The use of amino acid supplements in inherited metabolic disease. J Inherit Metab Dis 29:279–280PubMedCrossRef
Zurück zum Zitat Willard HF, Rosenberg LE (1980) Inherited methylmalonyl CoA mutase apoenzyme deficiency in human fibroblasts. Evidence for allelic heterogeneity, genetic compounds, and codominant expression. J Clin Invest 65:690–698PubMedCentralPubMedCrossRef Willard HF, Rosenberg LE (1980) Inherited methylmalonyl CoA mutase apoenzyme deficiency in human fibroblasts. Evidence for allelic heterogeneity, genetic compounds, and codominant expression. J Clin Invest 65:690–698PubMedCentralPubMedCrossRef
Metadaten
Titel
Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative?
verfasst von
Tamaris Zwickler
Gisela Haege
Alina Riderer
Friederike Hörster
Georg F. Hoffmann
Peter Burgard
Stefan Kölker
Publikationsdatum
01.09.2012
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 5/2012
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9426-1

Weitere Artikel der Ausgabe 5/2012

Journal of Inherited Metabolic Disease 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.